COMMUNIQUÉS West-GlobeNewswire

Novartis PARAGON-HF trial suggests Entresto® benefit in HFpEF patients but narrowly misses primary endpoint
01/09/2019
Entresto (sacubitril/valsartan) reduced the composite of total (first and recurrent) heart failure hospitalizations and cardiovascular death although narrowly missed statistical significance (p = 0.059)[1] Totality of [...]
Phase 2 data of aprocitentan, Idorsia’s dual endothelin receptor antagonist, presented at ESC 2019
31/08/2019
Phase 2 dose-finding study demonstrated the blood pressure lowering effect of aprocitentan A global Phase 3 study “PRECISION” in patients whose blood pressure remains uncontrolled despite receiving at least three [...]
MyoKardia Presents 36-week Data from PIONEER-OLE Study of Mavacamten at the European Society of Cardiology Congress 2019
31/08/2019
Durability of Mavacamten's Safety and Efficacy Profile Demonstrated through Nine Months in this Study of Patients with Symptomatic, Obstructive HCM Statistically Significant Changes in Key Biomarkers Maintained, [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31/08/2019
CAMBRIDGE, Mass., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on August 30, 2019, that were previously [...]
Dentsply Sirona to Present at the 2019 Baird Global Healthcare Conference on September 4th
30/08/2019
CHARLOTTE, N.C., Aug. 30, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that it will participate in the 2019 Baird Global Healthcare [...]
Eyecarrot to Participate in NORA 2019 Annual General Conference
30/08/2019
TORONTO, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Eyecarrot Innovations Corp. (EYC: TSX-V ) is thrilled to promote its participation in the Neuro-Optometric Rehabilitation Association (NORA) 2019 Annual General Conference, as [...]
Protalix BioTherapeutics Receives Listing Deficiency Letter from NYSE American
30/08/2019
CARMIEL, Israel, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30/08/2019
HOUSTON, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
30/08/2019
CHICAGO, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
30/08/2019
BOTHELL, Wash., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Transparency notification
30/08/2019
Mechelen, Belgium; 30 August 2019; 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Van Herk Investments B.V . Pursuant to Belgian transparency [...]
Morphic to Present at the Wells Fargo Securities 2019 Healthcare Conference
30/08/2019
WALTHAM, Mass., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, [...]
Idera Pharmaceuticals to Present at the Baird 2019 Global Healthcare Conference
30/08/2019
EXTON, Pa., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that the company will present at the Baird 2019 Global Healthcare Conference on Wednesday, September 4, 2019 at 8: [...]
Vical Stockholders Approve Reverse Stock Split and Merger with Brickell
30/08/2019
• Merger Transaction Expected to Close August 31, 2019 SAN DIEGO, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Vical Incorporated (“Vical”) (Nasdaq:VICL) announced that its stockholders voted to approve the proposals required to [...]
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
30/08/2019
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) reports the following transactions: 1. Details of the person discharging managerial responsibility / person closely associated a) Name Henrik Jacobi 2. Reason for the [...]
Afya Limited Reports 2Q19 Results
30/08/2019
NOVA LIMA, Brazil, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today reported financial and operating results for the second quarter of 2019. CEO Statement “The year of 2019 has been [...]
Total number of shares and voting rights in Zealand Pharma at August 31, 2019
30/08/2019
Company announcement – No. 28 / 2019 Copenhagen, August 30, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development [...]
Afya Limited Announces the Appointment of New Independent Member of Board of Directors and Audit Committee
30/08/2019
NOVA LIMA, Brazil, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA) today announced the appointment of Rafael Munerato de Almeida to its board of directors and audit committee as an independent [...]
Olainfarm Group’s financial performance in the first half reached new highs – sales were 66.4 million EUR; net profit jumps to 12.2 million EUR
30/08/2019
Group sales in the first half 2019 were 66.4 million EUR, which is 7% higher than a year earlier EBITDA margin for the first six month 2019 was 26%, up from 17% year ago Strong liquidity and decrease in leverage support [...]

Pages